Insider Trading: Celgene Corp (CELG.O)

CELG.O on Nasdaq

112.82USD
17 Dec 2014
Price Change (% chg)

-- (--)
Prev Close
$112.82
Open
--
Day's High
--
Day's Low
--
Volume
5,710
Avg. Vol
5,126,112
52-wk High
$119.84
52-wk Low
$66.85

Search Stocks
All Insider Trades
Trading Date Name Title Type Shares Traded Price
13 Aug 2014

Casey Michael D

Director Buy 30,000 $7.25
13 Aug 2014

Casey Michael D

Director Sell 30,000 $88.59
3 Aug 2014

KARSEN PERRY A

Officer Buy 46,450 $28.16
3 Aug 2014

KARSEN PERRY A

Officer Sell 39,104 $87.55
24 Jul 2014

Barker Richard W

Director Sell 17,600 $87.03
24 Jul 2014

Barker Richard W

Director Buy 18,600 $31.80
23 Jul 2014

Mario Ernest B

Director Buy 5,000 $27.69
15 Jun 2014

Mario Ernest B

Director Buy 2,055 $0.00
15 Jun 2014

Casey Michael D

Director Gift 3,100 $0.00
14 Jun 2014

Casey Michael D

Director Buy 1,034 $0.00
14 Jun 2014

Mario Ernest B

Director Buy 3,100 $0.00
14 Jun 2014

DRAKE RODMAN L

Director Buy 1,034 $0.00
12 Jun 2014

Friedman Michael A

Director Buy 1,033 $0.00
12 Jun 2014

Casey Michael D

Director Buy 1,033 $0.00
12 Jun 2014

Loughlin James J

Director Buy 1,033 $0.00
12 Jun 2014

Barker Richard W

Director Buy 1,033 $0.00
12 Jun 2014

Mario Ernest B

Director Buy 1,033 $0.00
12 Jun 2014

DRAKE RODMAN L

Director Buy 516 $0.00
12 Jun 2014

Barker Richard W

Director Sell 309 $159.99
12 Jun 2014

Kaplan Gilla

Director Buy 1,033 $0.00
11 Jun 2014

Barker Richard W

Director Buy 1,033 $0.00
11 Jun 2014

Friedman Michael A

Director Buy 1,033 $0.00
11 Jun 2014

Casey Michael D

Director Buy 1,033 $0.00
11 Jun 2014

Kaplan Gilla

Director Buy 1,033 $0.00
11 Jun 2014

Barker Richard W

Director Sell 309 $160.22

Institutional Holders

% Shares Owned: 84.03%
# of Holders: 1,404
Total Shares Held: 671,177,372
3 Mo. Net Change: 3,674,418
# New Positions: 114
# Closed Positions: 70
# Increased Positions: 575
# Reduced Positions: 585
# Net Buyers: -10

Officers & Directors

Name Age Since Current Position

Robert Hugin

59 2011 Chairman of the Board, President, Chief Executive Officer

Mark Alles

55 2014 President, Chief Operating Officer

Peter Kellogg

58 2014 Chief Financial Officer, Executive Vice President

Jacqualyn Fouse

52 2014 President - Hematology & Oncology

Tuomo Patsi

President - Europe, Middle East and Africa (EMEA)

Scott Smith

2014 President - Inflammation & Immunology

Perry Karsen

58 2012 Chief Operations Officer, Executive Vice President

Lawrence Stein

64 2012 Executive Vice President, General Counsel, Corporate Secretary

Thomas Daniel

60 2012 Executive Vice President, President - Research and Early Development

Michael Casey

68 2007 Lead Independent Director

Richard Barker

65 2012 Independent Director

Carrie Cox

57 2009 Independent Director

Michael Friedman

70 2011 Independent Director

Gilla Kaplan

67 1998 Independent Director

James Loughlin

71 2007 Independent Director

Ernest Mario

76 2007 Independent Director
Search Stocks